Search for: "Caremark, LLC" Results 1 - 20 of 79
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Feb 2024, 6:30 am
Danilack, Gibson, Dunn & Crutcher LLP, on Sunday, February 4, 2024 Tags: Activism, AI, Artificial intelligence, data analytics, Environment, litigation, Public disclosures, Risk management, SEC, Sustainability, technology Caremark Claim Based on Business Risks Dismissed Posted by Richard Horvath, Stephen Leitzell, and Taylor Jaszewski, Dechert LLP, on Monday, February 5, 2024 Tags: Business risk, Court of Chancery, Delaware Court of Chancery, Delaware law, In re Caremark,… [read post]
9 Feb 2024, 6:30 am
Danilack, Gibson, Dunn & Crutcher LLP, on Sunday, February 4, 2024 Tags: Activism, AI, Artificial intelligence, data analytics, Environment, litigation, Public disclosures, Risk management, SEC, Sustainability, technology Caremark Claim Based on Business Risks Dismissed Posted by Richard Horvath, Stephen Leitzell, and Taylor Jaszewski, Dechert LLP, on Monday, February 5, 2024 Tags: Business risk, Court of Chancery, Delaware Court of Chancery, Delaware law, In re Caremark,… [read post]
7 Dec 2023, 6:00 am by Levin Papantonio
LLC, and, on the PBM side, CVS Caremark, Express Scripts, Optum Rx, and their various corporate affiliates.LPR law firm has filed insulin pricing lawsuits against insulin manufacturers and pharmacy benefit managers (PBMs) on behalf of the Arizona Attorney General; Lake County, Illinois; City of Cleveland; Monmouth County, New Jersey; Albany County, New York; Pinellas County, FL; Arlington County, VA; City of Alexandria, VA; Washington County, MD; St. [read post]
25 Aug 2023, 5:58 pm
The March of Caremark: What must directors do to avoid landmines? [read post]
7 Aug 2023, 6:01 am by Levin Papantonio
LLC, and, on the PBM side, CVS Caremark, Express Scripts, Optum Rx, and their various corporate affiliates. [read post]
27 Mar 2023, 9:01 pm by renholding
Although the number of securities lawsuits filed this year remained steady compared to 2021, we have seen many notable developments in securities law. [read post]
10 Mar 2023, 6:30 am
Holland, Simpson Thacher & Bartlett LLP, on Saturday, March 4, 2023 Tags: anti-ESG, Corporate governance, ESG, Proxy advisors, Proxy voting, SEC Corporate Officers Owe the Same Caremark Oversight Duties as Directors Posted by Alan Stone, Jed Schwartz, and Neil Whoriskey, Milbank LLP, on Sunday, March 5, 2023 Tags: Board of Directors, Board oversight, Caremark, Delaware cases, Delaware Court of Chancery, Fiduciary duties Musings and Questions about the Universal Proxy… [read post]
10 Mar 2023, 6:30 am
Holland, Simpson Thacher & Bartlett LLP, on Saturday, March 4, 2023 Tags: anti-ESG, Corporate governance, ESG, Proxy advisors, Proxy voting, SEC Corporate Officers Owe the Same Caremark Oversight Duties as Directors Posted by Alan Stone, Jed Schwartz, and Neil Whoriskey, Milbank LLP, on Sunday, March 5, 2023 Tags: Board of Directors, Board oversight, Caremark, Delaware cases, Delaware Court of Chancery, Fiduciary duties Musings and Questions about the Universal Proxy… [read post]
10 Feb 2023, 7:04 am
McIntosh, Wachtell, Lipton, Rosen & Katz, on Monday, February 6, 2023 Tags: Corporate governance, CSRD, Elon Musk, ESG, Esg governance, Wachtell Lipton Corporate Officers, Not Just Directors, Can Be Liable for Duty of Oversight Violations Posted by Jonathan Youngwood, Nicholas Goldin, and Stephen Blake, Simpson Thacher & Bartlett LLP, on Tuesday, February 7, 2023 Tags: Caremark, Delaware Court of Chancery, Derivative suits, Duty of oversight, ESG, Oversight Proxy voting… [read post]
10 Feb 2023, 7:04 am
McIntosh, Wachtell, Lipton, Rosen & Katz, on Monday, February 6, 2023 Tags: Corporate governance, CSRD, Elon Musk, ESG, Esg governance, Wachtell Lipton Corporate Officers, Not Just Directors, Can Be Liable for Duty of Oversight Violations Posted by Jonathan Youngwood, Nicholas Goldin, and Stephen Blake, Simpson Thacher & Bartlett LLP, on Tuesday, February 7, 2023 Tags: Caremark, Delaware Court of Chancery, Derivative suits, Duty of oversight, ESG, Oversight Proxy voting… [read post]
18 Nov 2022, 6:30 am
Bebchuk, Kobi Kastiel, Anna Toniolo (Harvard Law School), on Monday, November 14, 2022 Tags: Corporate disputes, Mergers & acquisitions, Poison pills, Stakeholders, Twitter SEC Finalizes New Clawback Rules Posted by Mike Kesner, Lane Ringlee, Pay Governance LLC, on Tuesday, November 15, 2022 Tags: Clawbacks, Compensation disclosure, Dodd-Frank Act, Financial reporting, SEC, SEC rulemaking Does Voluntary Financial Disclosure Matter? [read post]
18 Nov 2022, 6:30 am
Bebchuk, Kobi Kastiel, Anna Toniolo (Harvard Law School), on Monday, November 14, 2022 Tags: Corporate disputes, Mergers & acquisitions, Poison pills, Stakeholders, Twitter SEC Finalizes New Clawback Rules Posted by Mike Kesner, Lane Ringlee, Pay Governance LLC, on Tuesday, November 15, 2022 Tags: Clawbacks, Compensation disclosure, Dodd-Frank Act, Financial reporting, SEC, SEC rulemaking Does Voluntary Financial Disclosure Matter? [read post]
12 Aug 2022, 6:51 am
Niles, Wachtell, Lipton, Rosen & Katz, on Tuesday, August 9, 2022 Tags: Board oversight, Boards of Directors, Compliance & ethics, Corporate liability, Delaware cases, Delaware law, In re Caremark, Risk Second Circuit on Stating a Claim for Scheme Liability Posted by Israel David, Samuel P. [read post]
12 Aug 2022, 6:51 am
Niles, Wachtell, Lipton, Rosen & Katz, on Tuesday, August 9, 2022 Tags: Board oversight, Boards of Directors, Compliance & ethics, Corporate liability, Delaware cases, Delaware law, In re Caremark, Risk Second Circuit on Stating a Claim for Scheme Liability Posted by Israel David, Samuel P. [read post]
10 Aug 2022, 2:44 pm by Unknown
Nuclear Regulatory Commission (National Environmental Policy Act; National Historic Preservation Act) Caremark LLC v. [read post]
29 Apr 2022, 6:27 am
Kay, and John Ellerman, Pay Governance LLC, on Monday, April 25, 2022 Tags: Compensation disclosure, Dodd-Frank Act, Executive Compensation, Incentives, Pay for performance, Say on pay, SEC, Securities regulation Do Startups Benefit from Their Investors’ Reputation? [read post]